Calendar Ascendis Pharma A/S

Equities

ASND

US04351P1012

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
135.9 USD -0.75% Intraday chart for Ascendis Pharma A/S -3.05% +7.90%

Chart calendar Ascendis Pharma A/S

eaedea.Zd1L9xand3Rr1m87Kb4LXllHVqLgZu9Vu9jZa9cVYq4.KLkqmEPDMUAohTdCT_dRC293M_iwFr8S3OCOKOB7JeVcmniUQuokOjiaPg~616059d0645af181e1b6738030ee56d9

Upcoming events on Ascendis Pharma A/S

02/05/2024 21:01 Q1 2024 Earnings Release
02/05/2024 21:30 Q1 2024 Earnings Call
28/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
01/04/2025 Q4 2024 Earnings Release (Projected)
20/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Ascendis Pharma A/S

11/03/2024 18:00 Leerink Partners Global Biopharma Conference
13/02/2024 21:00 Oppenheimer Healthcare Life Sciences Conference
07/02/2024 21:30 Q4 2023 Earnings Call
07/02/2024 21:01 Q4 2023 Earnings Release
08/01/2024 17:00 JPMorgan Healthcare Conference
07/11/2023 21:30 Q3 2023 Earnings Call
07/11/2023 21:01 Q3 2023 Earnings Release
15/10/2023 American Association of Bone & Mineral Research Meeting - Poster No - #1114
20/09/2023 European Society for Paediatric Endocrinology Meeeting - Poster Number: LB-17
12/09/2023 17:55 Morgan Stanley Global Healthcare Conference
08/09/2023 13:00 Wells Fargo Healthcare Conference
07/09/2023 19:40 Citi BioPharma Conference
05/09/2023 21:30 Q2 2023 Earnings Call
05/09/2023 21:03 Q2 2023 Earnings Release
17/06/2023 22:30 Endocrine Society Meeting
17/06/2023 19:00 Endocrine Society Meeting - Poster No : SAT-233
17/06/2023 19:00 Endocrine Society Meeting - Poster No : SAT-611
15/06/2023 18:30 Endocrine Society Meeting - Poster No : THU-156
15/06/2023 18:30 Endocrine Society Meeting - Poster No : THU-173
15/06/2023 18:30 Endocrine Society Meeting - Poster No : THU-164

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
13,4
12,4
8.01%
6,95
8,81
-21.06%
7,78
6,54
18.86%
51,2
45,5
12.57%
267
216
23.67%

425

EBITDA
Million EUR
Released
Forecast
Spread
-220
-214
-2.66%
-321
-301
-6.59%
-436
-436
-0.17%
-544
-535
-1.62%
-437
-506
13.77%

-300

EBIT
Million EUR
Released
Forecast
Spread
-227
-219
-3.4%
-331
-308
-7.41%
-452
-453
0.36%
-562
-556
-1.13%
-456
-516
11.77%

-270

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-218
-196
-11.37%
-419
-353
-18.58%
-384
-408
5.85%
-578
-543
-6.35%
-474
-471
-0.57%

-222

Net income
Million EUR
Released
Forecast
Spread
-218
-196
-11.43%
-419
-354
-18.23%
-384
-406
5.5%
-583
-530
-10.02%
-481
-493
2.26%

-236

EPS
EUR
Released
Forecast
Spread
-4,69
-4,18
-12.11%
-8,28
-6,98
-18.6%
-7,00
-7,49
6.52%
-10,4
-9,56
-8.82%
-8,55
-8,63
0.95%

-4,29

Announcement Date01/04/2010/03/2102/03/2216/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million EUR
Released
Forecast
Spread
4,90
2,66
84.06%
6,83
4,47
52.64%
6,16
5,81
6.02%
15,3
8,81
73.57%
22,9
18,8
21.49%
33,6
21,5
56.04%
47,4
37,4
26.84%
48,0
48,0
0.09%
138
85,6
60.86%

79,8


91,1


115


144


178

EBITDA
Million EUR
Released
Forecast
Spread
-108
-128
15.39%
-124
-116
-6.56%
-138
-110
-24.56%
-140
-122
-14.88%



-139
-140
0.61%



-130
-128
-1.3%
-31,6
-40,0
20.92%

-75,5


-65,5


-46,7


-23,8




EBIT
Million EUR
Released
Forecast
Spread
-113
-120
6.23%
-128
-117
-9.15%
-142
-128
-11.25%
-145
-143
-1.02%
-147
-144
-2.29%
-144
-150
4.34%
-141
-144
2.16%
-134
-135
0.6%
-36,6
-97,9
62.61%

-87,4


-73,7


-51,0


-21,1


10,0

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-106
-125
15.19%
-125
-118
-6.41%
-81,4
-129
36.95%
-169
-140
-20.97%
-202
-149
-35.55%
-110
-153
28.57%
-122
-141
13.32%
-162
-128
-26.16%
-81,1
-71,9
-12.84%

-79,2


-67,3


-42,8


-12,4


22,0

Net income
Million EUR
Released
Forecast
Spread
-106
-124
14.76%
-125
-115
-8.71%
-81,3
-120
31.99%
-169
-142
-19.17%
-207
-138
-50.04%
-111
-153
27.52%
-121
-144
15.61%
-162
-133
-21.99%
-86,9
-93,2
6.82%

-82,4


-70,4


-48,3


-21,1


17,0

EPS
EUR
Released
Forecast
Spread
-1,87
-2,31
18.93%
-2,21
-1,99
-10.85%
-1,46
-2,11
30.81%
-3,03
-2,53
-19.95%
-3,70
-2,48
-49.06%
-1,98
-2,71
26.97%
-2,16
-2,56
15.63%
-2,88
-2,35
-22.52%
-1,54
-1,57
2.15%

-1,43


-1,22


-0,81


-0,31


0,31

Announcement Date02/03/2211/05/2210/08/2202/11/2216/02/2327/04/2305/09/2307/11/2307/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ASND Stock
  4. Calendar Ascendis Pharma A/S